Abstracts
57
This presentation will review emerging and established evi-
dence for elective and therapeutic neck dissection and discuss
clinical decision-making for individual patients based on the data
available. The topics of pre-test probability, sensitivity and speci-
ficity will be covered in the context of diagnostic and surgical
adjuncts for recommending neck dissection considering tumour
specific characteristics including tumour location, size, and pat-
terns of invasion as well as patient factors including age and
medical comorbidities. The presentation will support the con-
cept that personalised surgical decisions amalgamate all available
information for recommendations that are both evidence based
and patient specific.
http://dx.doi.org/10.1016/j.ijom.2017.02.207Treatment recommendations for the neck in the clinically node
positive neck oral cavity cancer patient
B. Ward
University of Michigan Hospital, United States
Optimal treatment of the clinically node positive neck (cN+) in
oral cavity cancer continues to be debated. Comprehensive versus
selective neck dissection in a variety of forms have been advocated.
This presentation will discuss current available evidence available
to guide clinicians in this important decision.
http://dx.doi.org/10.1016/j.ijom.2017.02.208The frontiers in modern oral and maxillofacial surgery: hopes
and limitations with regards to tissue engineering
P. Warnke
University of Kiel, Kiel, Germany
Cancer surgery in the head and neck region often leads to signif-
icant and disfiguring defects. Subsequent tissue repair remains a
challenge for the surgeon. Cancer survivors may suffer from aes-
thetic and functional impairment that result in a reduced quality of
life. However, latest stem cell and tissue engineering techniques
may offer the potential to grow body parts anew. There is hope
that this may even allow to grow entire organ replacements with
the patient’s own cells in the future, thus making the complicated
search for organ donors redundant.
This talk will outline pioneering strategies for complex tissue
regeneration and repair in oral and maxillofacial surgery. Current
techniques and the goals for future use of adult stem cells and
computer assisted ‘perfect fit’ organ design will be outlined. Fur-
thermore the hurdles to translate novel techniques from bench to
bedside and the limitations for cell applications in clinical practice
will be explained.
http://dx.doi.org/10.1016/j.ijom.2017.02.209Meeting the challenges of multidisciplinary head and neck
cancer care
D. Wiesenfeld
Victorian Comprehensive Cancer Centre, Melbourne, Australia
Head and neck cancer presents a challenge for management
throughout the world, with more than 550,000 cases and 300,000
deaths per annum, not including thyroid cancer. There are a broad
range of pathological types including squamous cell carcinoma,
salivary gland carcinoma and a variety of sarcomas. Many clini-
cal disciplines with differing education and training are managing
these patients, including surgeons and physicians.
It is widely accepted including within Australia, that head and
neck cancer patients are best managed in multidisciplinary (MD)
clinics by appropriately trained and credentialed practitioners.
The MD Team (MDT) includes surgeons, oral and maxillo-
facial, otolaryngology, head and neck, plastic and reconstructive,
and general as regular participants, neuro and thoracic surgeons
participate in selected cases. Physicians, radiation and medical
oncologists, radiologists, pathologists and nuclear medicine are
required. The full range of specialist dentists, allied health practi-
tioners and nurses are essential team members.
The MD Meeting, prior to commencing treatment, should
review individual patients with appropriate clinical information.
A consensus approach to management is generally achieved,
acknowledging the responsible clinician for each patient.
The MDT is also responsible for clinical teaching and training
at both undergraduate and postgraduate levels.
Research in all aspects of head and neck cancer, clinical, trans-
lational and laboratory is encouraged and supported by the MDT
There are many challenges toMD care in head and neck cancer,
including inter-professional rivalry, a commitment to quality care,
research and training by teammembers. Institutional commitment,
resources and funding must be achieved for success and improved
patient outcome.
http://dx.doi.org/10.1016/j.ijom.2017.02.210Reconstructive concepts for tumours invading the facial skin
K.D. Wolff
Klinikum rechts der Isar der Technischen Universität München,
Munich, Germany
If tumours of the head and neck involve the facial skin, strategies of
reconstruction must follow the aim of achieving the best possible
aesthetic result. Other than in the oral cavity where the use of
free tissue transfer has become a standard procedure, method of
the first choice is the use of local flaps under consideration of the
aesthetic units and relaxed skin tension lines of the face. Whereas
this principle can be applied in many cases of small or medium
sized skin cancers, advanced tumours with deep infiltration of the
surrounding tissues must often be treated using free tissue transfer.
In challenging cases, combinations with additional local flaps or
epitheses are necessary. In the lecture, a schematic procedure of
reconstructive steps and a choice of the most useful free flaps are
presented. Moreover, basic considerations about the indication for
surgery and its limitations are discussed.
http://dx.doi.org/10.1016/j.ijom.2017.02.211Technical developments in maxillofacial reconstruction
K.D. Wolff
Klinikum rechts der Isar der Technischen Universität München,
Munich, Germany
Since more than three decades, microvascular tissue transfer is a
proven procedure, but challenges still remain. An increasing num-
ber of patients present with comorbidities, in old age or with an
irradiated and vessel depleted neck. Advances of intra- and periop-
erative patient care as well as methods like vascular loops, reverse




